FLEURY (FLRY3) Main Indicators
Basic Data - FLRY3
| Company | FLEURY |
| Corporate Name | FLEURY S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | (i) prestação de serviços médicos e medicina diagnóstica; (ii) consultoria. assessoria. cursos. gestão de doenças crônicas; (iii) pesquisa e desenvolvimento; (iv) a prestação de serviços a terceiros |
| Share | FLRY3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 11.70 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 36.11 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Saúde |
| Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
| Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
| Participation Indexes | IBOVESPA, IBRA, IBRX, ICO2, ICON, IDIV, IGC, IGCT, IGNM, ISE, ITAG, SMLL |
| Updated 04/02/2025 | |
Relative Prices - FLRY3
| Price/Earnings | 10.39 |
| Price/SBV | 1.21 |
| Price/Net Sales | 0.83 |
| Price/CFO | 3.32 |
| Price/FCF | 4.44 |
| Price/Total Assets | 0.49 |
| Price/EBIT | 5.35 |
| Price/Working Capital | 2.43 |
| Price/NCAV | -1.25 |
| EV/EBIT | 9.83 |
| EV/EBITDA | 5.95 |
| EV/Net Sales | 1.53 |
| EV/CFO | 6.10 |
| EV/FCF | 8.16 |
| EV/Total Assets | 0.90 |
| Company Market Cap | R$ 6.40 B |
| Enterprise Value | R$ 11.77 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 11.70 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 8.70% |
| Updated 04/02/2025 | |
Income Statement - FLRY3
| Net Revenue | R$ 7.68 B |
| Gross Result | R$ 2.14 B |
| EBIT | R$ 1.20 B |
| Depreciation and Amortization | - R$ 779.98 M |
| EBITDA | R$ 1.98 B |
| Net Profit | R$ 616.17 M |
| Net Profit/Share | R$ 1.13 |
| Updated 02/27/2025 | |
| Net Revenue | R$ 1.84 B |
| Gross Result | R$ 453.55 M |
| EBIT | R$ 200.93 M |
| Depreciation and Amortization | - R$ 202.02 M |
| EBITDA | R$ 402.95 M |
| Net Profit | R$ 83.92 M |
| Profit/Share | R$ 0.15 |
| Updated 02/27/2025 | |
Price and Volume Behavior - FLRY3
| Lowest Price 52 weeks | R$ 10.64 |
| Highest Price 52 weeks | R$ 15.86 |
| Variation 2025 | 1.33% |
| Variation 1 year | -14.91% |
| Variation 2 years(total) | -5.11% |
| Variation 2 years(yearly) | -2.58% |
| Variation 3 years(total) | -15.48% |
| Variation 3 years(yearly) | -5.45% |
| Variation 4 years(total) | -42.33% |
| Variation 4 years(yearly) | -12.85% |
| Variation 5 years(total) | -23.78% |
| Variation 5 years(yearly) | -5.28% |
| Average Daily Volume (3 months) | R$ 39.68 M |
| Updated 04/02/2025 | |
Returns and Margins - FLRY3
| Return on Initial Tangible Capital | 17.02% |
| Return on Initial Invested Capital | 8.50% |
| Pre-Tax Return on Initial Tangible Capital | 25.79% |
| Pre-Tax Return on Initial Invested Capital | 12.88% |
| Return on Initial Shareholder´s Equity | 12.12% |
| Return on Initial Asset | 5.32% |
| Gross Margin | 27.89% |
| Net Margin | 8.02% |
| EBIT Margin | 15.59% |
| EBITDA Margin | 25.74% |
| Initial Asset Turnover | 0.66 |
| Financial Leverage | 2.47 |
| Liabilities/Net Worth | 1.47 |
| Net Debt/EBITDA | 2.72 |
| Updated 02/27/2025 | |
Balance Sheet - FLRY3
| Cash and Cash Equivalents | R$ 21.79 M |
| Total Assets | R$ 13.06 B |
| Short-Term Debt | R$ 497.61 M |
| Long-Term Debt | R$ 4.89 B |
| Gross Debt | R$ 5.39 B |
| Net Debt | R$ 5.37 B |
| Shareholder´s Equity | R$ 5.29 B |
| Share Book Value | R$ 9.67 |
| Common Shares | 547,191,026 |
| Preferred Shares | 0 |
| Total | 547,191,026 |
| Common Shares in Treasury | 2,911,287 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 2,911,287 |
| Common Shares (Except Treasury) | 544,279,739 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 544,279,739 |
| Updated 02/27/2025 | |
Cash Flow - FLRY3
| Operating Cash Flow | R$ 1.93 B |
| Cash Flow from Investments | - R$ 2.06 B |
| Financing Cash Flow | R$ 126.01 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 132.00 thousand |
| Updated 02/27/2025 | |
| Operating Cash Flow | R$ 563.64 M |
| Cash Flow from Investments | - R$ 289.56 M |
| Financing Cash Flow | - R$ 264.93 M |
| Increase (Reduction) in Cash and Equivalents | R$ 9.15 M |
| Updated 02/27/2025 | |
Experimental - FLRY3
| CAPEX 3 months | - R$ 210.56 M |
| Free Cash Flow 3 months | R$ 353.08 M |
| CAPEX 12 months | - R$ 488.12 M |
| Free Cash Flow 12 months | R$ 1.44 B |
| Updated 02/27/2025 | |